This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bousejra-El Garah, F.
Right arrow Articles by Robert, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bousejra-El Garah, F.
Right arrow Articles by Robert, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2008, p. 2966-2969, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.00165-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Antimalarial Trioxaquine DU1301 Alkylates Heme in Malaria-Infected Mice{triangledown}

Fatima Bousejra-El Garah,1 Catherine Claparols,1 Françoise Benoit-Vical,1,2 Bernard Meunier,3 and Anne Robert1*

Laboratoire de Chimie de Coordination du CNRS, 205 route de Narbonne, 31077 Toulouse Cedex 4, France,1 Service de Parasitologie et Mycologie, CHU Rangueil, Université de Toulouse, TSA 50032, 31059 Toulouse Cedex 9, France,2 Palumed, rue Pierre et Marie Curie, BP 28262, 31682 Labège Cedex, France3

Received 5 February 2008/ Returned for modification 6 March 2008/ Accepted 3 June 2008

The in vivo alkylation of heme by the antimalarial trioxaquine DU1301 afforded covalent heme-drug adducts that were detected in the spleens of Plasmodium sp.-infected mice. This result indicates that the alkylation capacities of trioxaquines in mammals infected with Plasmodium strains are similar to that of artemisinin, a natural antimalarial trioxane-containing drug.


* Corresponding author. Mailing address: Laboratoire de Chimie de Coordination du CNRS, 205 route de Narbonne, 31077 Toulouse Cedex 4, France. Phone: 33 5 61 33 31 26. Fax: 33 5 61 55 30 03. E-mail: anne.robert{at}lcc-toulouse.fr

{triangledown} Published ahead of print on 16 June 2008.


Antimicrobial Agents and Chemotherapy, August 2008, p. 2966-2969, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.00165-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Cosledan, F., Fraisse, L., Pellet, A., Guillou, F., Mordmuller, B., Kremsner, P. G., Moreno, A., Mazier, D., Maffrand, J.-P., Meunier, B. (2008). Selection of a trioxaquine as an antimalarial drug candidate. Proc. Natl. Acad. Sci. USA 105: 17579-17584 [Abstract] [Full Text]